Human Thymosin beta-4 PharmaGenie ELISA Kit (SBRS0174)

Quantitative measurement of human Thymosin beta-4 is supported by this competitive ELISA from Assay Genie, configured in a 96 assays format. The 4.9 kDa actin-sequestering peptide is quantified in samples derived from cell culture supernatants, plasma specimens, and serum specimens, supporting research into wound healing, tissue regeneration, cell motility, and angiogenesis.

The assay supports in vitro investigation of Thymosin beta-4 expression across dermatology, cardiac repair, ophthalmology, and oncology research areas. Reconstituted reagents are aliquoted and refrigerated between runs to preserve activity. All kit components are supplied in single use vials and tubes sufficient for 96 determinations.

Intended for research use only, this competitive ELISA accommodates biomarker discovery and longitudinal treatment-response studies. Researchers can profile Thymosin beta-4 levels in disease models of fibrosis, inflammatory signaling, and regenerative biology, with reactivity limited to human samples.